Viral Clearance, PK and Tolerability of Ensovibep in COVID-19 Patients
Status:
Completed
Trial end date:
2021-08-20
Target enrollment:
Participant gender:
Summary
This study will investigate how ensovibep is distributed throughout the body, the viral
clearance and the tolerability of ensovibep in patients with symptomatic COVID-19 disease